Carotid artery stenting: an update.
- Cremonesi A Interventional Cardiovascular Unit, GVM Care and Research, Maria Cecilia Hospital, Cotignola, Italy cremonesi.a@gmail.com acremonesi@gvmnet.it cremonesialberto@hotmail.com.
- Castriota F Interventional Cardiovascular Unit, GVM Care and Research, Maria Cecilia Hospital, Cotignola, Italy.
- Secco GG Maggiore Della Carità Hospital, University of Eastern Piedmont, Novara, Italy.
- Macdonald S Department of Radiology, Freeman Hospital, Newcastle upon Tyne, UK.
- Roffi M Division of Cardiology, University Hospital, Geneva, Switzerland.
- 2014-12-24
Published in:
- European heart journal. - 2015
Carotid artery stenosis
Carotid artery stenting
Carotid endarterectomy
Emboli protection
Randomized controlled trials
Biomedical Technology
Carotid Stenosis
Endarterectomy, Carotid
Forecasting
Humans
Prosthesis Design
Randomized Controlled Trials as Topic
Reperfusion
Stents
Stroke
English
In patients with carotid disease, the purpose of carotid artery revascularization is stroke prevention. For >50 years, carotid endarterectomy has been considered the standard treatment for severe asymptomatic and symptomatic carotid stenoses. Carotid artery stenting (CAS) has emerged in the last 15 years as minimally invasive alternative to surgery. However, the value of the endovascular approach in the management of carotid disease patients remains highly controversial. The aims of this review are to elucidate the current role of CAS, to describe the major technology advancements in the field, and to speculate about the future of this therapy.
- Language
-
- English
- Open access status
- hybrid
- Identifiers
-
- DOI 10.1093/eurheartj/ehu446
- PMID 25535085
- Persistent URL
- https://sonar.ch/global/documents/109121
Statistics
Document views: 26
File downloads:
- fulltext.pdf: 0